MCF Advisors’s Quest Diagnostics DGX Stock Holding History

MCF Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.6K	Hold	187	–	–	﹤0.01%	732
2026 Q1	$36.6K	Hold	187	–	–	﹤0.01%	672
2025 Q4	$32.5K	Hold	187	–	–	﹤0.01%	592
2025 Q3	$35.6K	Hold	187	–	–	﹤0.01%	474
2025 Q2	$33.6K	Hold	187	–	–	﹤0.01%	469
2025 Q1	$31.6K	Sell	187 -5	-3%	-$821	﹤0.01%	470
2024 Q4	$29K	Hold	192	–	–	﹤0.01%	483
2024 Q3	$29.8K	Sell	192 -99	-34%	-$14.8K	﹤0.01%	479
2024 Q2	$39.8K	Hold	291	–	–	﹤0.01%	427
2024 Q1	$38.7K	Hold	291	–	–	﹤0.01%	418
2023 Q4	$40.1K	Buy	291 +187	+180%	+$24.6K	﹤0.01%	402
2023 Q3	$12.7K	Buy	104 +99	+1,980%	+$13.2K	﹤0.01%	547
2023 Q2	$703	Hold	5	–	–	﹤0.01%	811
2023 Q1	$708	Hold	5	–	–	﹤0.01%	797
2022 Q4	$782	Hold	5	–	–	﹤0.01%	761
2022 Q3	$1K	Hold	5	–	–	﹤0.01%	728
2022 Q2	$1K	Hold	5	–	–	﹤0.01%	686
2022 Q1	$1K	Buy	+5	New	+$697	﹤0.01%	693
2021 Q4	–	Sell	-5	Closed	-$1K	–	201
2021 Q3	$1K	Buy	+5	New	+$732	﹤0.01%	672
2020 Q3	–	Sell	-31	Closed	-$4K	–	473
2020 Q2	$4K	Buy	+31	New	+$3.29K	﹤0.01%	414
2016 Q3	–	Sell	-35	Closed	-$3K	–	468
2016 Q2	$3K	Buy	+35	New	+$2.67K	﹤0.01%	430

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

MCF Advisors's DGX Position: Q2 2026 in Review

MCF Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 187 shares worth $39.6K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

MCF Advisors first reported a position in DGX in Q2 2016 and has held it in 21 quarters since. The position peaked at $40.1K in Q4 2023. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

MCF Advisors held 187 shares of Quest Diagnostics worth $39.6K as of Q2 2026.
MCF Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #732 holding.
MCF Advisors first reported a position in Quest Diagnostics in Q2 2016 and has held it in 21 quarters since.
MCF Advisors's Quest Diagnostics position peaked at $40.1K in Q4 2023.
1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.